You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 12, 2024

VISKEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Visken, and what generic alternatives are available?

Visken is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in VISKEN is pindolol. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pindolol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Visken

A generic version of VISKEN was approved as pindolol by AUROBINDO PHARMA USA on September 3rd, 1992.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VISKEN?
  • What are the global sales for VISKEN?
  • What is Average Wholesale Price for VISKEN?
Summary for VISKEN
Drug patent expirations by year for VISKEN
Recent Clinical Trials for VISKEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of OttawaPhase 1
NovartisN/A
Danish Heart FoundationN/A

See all VISKEN clinical trials

US Patents and Regulatory Information for VISKEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis VISKEN pindolol TABLET;ORAL 018285-001 Sep 3, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis VISKEN pindolol TABLET;ORAL 018285-002 Sep 3, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.